Patent details

EP2254570 Title: COMBINATION COMPRISING PACLITAXEL FOR TREATING OVARIAN CANCER

Basic Information

Publication number:
EP2254570
PCT Application Number:
PCT/IB/2009/050677
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097123343
PCT Publication Number:
WO/2009/104149
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION COMPRISING PACLITAXEL FOR TREATING OVARIAN CANCER
French Title of Invention:
COMBINAISON COMPRENANT DU PACLITAXEL DESTINÉE AU TRAITEMENT DU CANCER DES OVAIRES
German Title of Invention:
KOMBINATION MIT PACLITAXEL ZUR BEHANLDUNG VON EIERSTOCKKREBS
SPC Number:

Dates

Filing date:
19/02/2009
Grant date:
18/12/2013
EP Publication Date:
18/12/2013
PCT Publication Date:
27/08/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/12/2010
EP B1 Publication Date:
18/12/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/02/2016
Expiration date:
19/02/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/02/2009
 
 

Name:
Actelion Pharmaceuticals Ltd.
Address:
Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/01/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CLOZEL Martine
Address:
Switzerland (CH)

2

Name:
REGENASS Urs
Address:
Switzerland (CH)

Priority

Priority Number:
8/050607
Priority Date:
20/02/2008
Priority Country:
International Bureau of WIPO (IB)

Classification

Main IPC Class:
A61K 31/216;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
18/02/2015
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages